Related pages Drug Information Summaries Approval Process for New Cancer Treatments Access to Investigational Drugs: Q & A

This page contains brief information about tamoxifen citrate and a collection of links to more information from the National Cancer Institute (NCI) and the National Library of Medicine (NLM).

US Brand Name(s):		Nolvadex
FDA Approved:		Yes

Tamoxifen citrate is approved by the Food and Drug Administration (FDA) to treat breast cancer in women and men. Tamoxifen is also approved to decrease the chance of developing breast cancer in women who are at high risk for this disease.

Tamoxifen citrate is also being studied in the treatment of other types of cancer.

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trial Results: Zoledronic Acid Improves Early Breast Cancer Treatment (06/19/2008) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole, Tamoxifen, and Bone Loss on the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial (03/26/2008) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Studies Affirm Tamoxifen's Long-Term Preventive Benefit (03/07/2007) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Aromatase Inhibitors Better than Tamoxifen for Advanced Breast Cancer (10/10/06) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Nonhormonal Therapies and Hot Flashes (05/10/2006) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Letrozole More Effective Than Tamoxifen (01/17/2006) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Breast Cancer Option - Anastrozole After Tamoxifen (08/30/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole Before Surgery for Large Breast Tumors (08/30/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Results of the Study of Tamoxifen and Raloxifene (STAR) Released: Raloxifene as Effective as Tamoxifen in Preventing Invasive Breast Cancer (04/17/2006) - Information from the NCI Press Office about this drug.

Benefits and Risks of Tamoxifen are Similar in African American and White Women (11/30/2004) - Information from the NCI Press Office about this drug.

Breast Cancer Prevention Studies (06/01/2005) - Information about the use of this drug to treat cancer.

Tamoxifen: Questions and Answers (05/13/2002) - Information about the use of this drug to treat cancer.

MedlinePlus Information on Tamoxifen Citrate - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,
• what this drug is used for and how it is used,
• what you should tell your doctor before using this drug,
• what you should know about this drug before using it,
• other drugs that may interact with this drug, and
• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials for Tamoxifen Citrate - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Back to Top